Sign in Create account

Fortis Malar Hospitals Limited

Healthcare · Healthcare Services

BSE: 523696
₹41.72
▼ -0.16 (-0.38%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
68/100
Moderate
Valuation
37/100
Fairly Valued
Momentum
43/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹78 Cr
PE (TTM)
417.2
Industry median 50.2 (44 companies)
Price to Book
2.3
PEG (TTM)
-4.3
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-28.3
Free Cash Flow
₹1 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
-95.96%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
-95.63%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
0.00%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
-95.76%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
-73.29%
as of March 31, 2024
Industry median 18.84% (52 companies)
Current Ratio
11.33
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
1392.67
as of Sept. 30, 2025
Industry median 7.94 (57 companies)
Net Margin
1015.49%
as of March 31, 2024
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
1107.26%
as of March 31, 2024
Industry median 17.21% (61 companies)
Operating Margin (TTM)
1.20%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
11.37%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
14.02%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
12.30%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 7 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (12.3%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Sell Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.4%
Low 41.2300 · High 42.3500
1W return
0.2%
Low 40.8000 · High 42.5000
1M return
-8.9%
Low 40.0000 · High 47.3000
52W return
-31.1%
Low 40.0000 · High 50.9500
Lifetime High ₹107.9400 (April 22, 2024)
Lifetime Low ₹9.5500 (Nov. 26, 2008)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
41.7
10D
42.0
20D
43.4
50D
48.9
100D
54.6
200D
60.1

Delivery and volume

Day avg. delivery
81.4%
Week avg. delivery
78.5%
Month avg. delivery
81.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

41.77
Pivot
First resistance42.30
Second resistance42.89
Third resistance43.42
First support41.18
Second support40.65
Third support40.06
Day RSI30.0
Day MFI40.2
Day MACD-2.25
Day MACD signal-2.63

Beta

1M-0.25
3M-0.16
1Y-0.16
3Y-0.06

Price change analysis

↓ -8.9%
Over 1 Month
LowHigh
40.0047.30
↓ -31.1%
Over 3 Months
LowHigh
40.0050.95
↓ -31.1%
Over 6 Months
LowHigh
40.0050.95
↓ -31.1%
Over 1 Year
LowHigh
40.0050.95
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 417.2 (own history: 1.8–605.1)
Sell Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹1 Cr
Net profit (June 30, 2026)
₹0 Cr
Basic EPS (June 30, 2026)
₹0.0900

Ranks #46 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter62.71%
  • Mutual funds0.07%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 62.71% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.07% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 47 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
14 Jun 2024 SAHASTRAA ADVISORS PRIVATE LIMITED Bulk Sell 100,000 70.9300 BSE
10 Jun 2024 SAHASTRAA ADVISORS PRIVATE LIMITED Bulk Buy 555 58.1600 BSE
10 Jun 2024 SAHASTRAA ADVISORS PRIVATE LIMITED Bulk Sell 96,495 58.8000 BSE
6 Jun 2024 SAHASTRAA ADVISORS PRIVATE LIMITED Bulk Sell 89,544 56.1300 BSE
6 Jun 2024 SAHASTRAA ADVISORS PRIVATE LIMITED Bulk Buy 150,356 56.4200 BSE
27 May 2024 SAHASTRAA ADVISORS PRIVATE LIMITED Bulk Buy 100,000 65.9300 BSE
23 Apr 2024 CAMELLIA TRADEX PRIVATE LIMITED Bulk Sell 100,000 67.4000 BSE
23 Apr 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 239,000 70.1100 BSE
22 Apr 2024 CAMELLIA TRADEX PRIVATE LIMITED Bulk Buy 100,000 107.9400 BSE
22 Apr 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Buy 246,122 107.9400 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from MALAR HOSPITALS LTD. to Fortis Malar Hospitals Limited

All corporate actions →

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
25 Sep 2026 Insider Trading / SAST Fortis Malar Hospitals Ltd - 523696 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (1015.5%)
  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (1392.7x)

Weaknesses

  • Declining revenue YoY (-73.3%)
  • Declining profit YoY (-95.8%)

Opportunities

  • RSI in oversold territory (30.0) -- a technical rebound zone

Threats

  • PE above 35 (417.2) -- priced for continued strong execution
  • Down 31.1% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Fortis Malar Hospitals Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.